A citation-based method for searching scientific literature

Jonathan A C Sterne, Alex J Sutton, John P A Ioannidis, Norma Terrin, David R Jones, Joseph Lau, James Carpenter, Gerta Rücker, Roger M Harbord, Christopher H Schmid, Jennifer Tetzlaff, Jonathan J Deeks, Jaime Peters, Petra Macaskill, Guido Schwarzer, Sue Duval, Douglas G Altman, David Moher, Julian P T Higgins. BMJ 2011
Times Cited: 2932







List of co-cited articles
90 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Bias in meta-analysis detected by a simple, graphical test.
M Egger, G Davey Smith, M Schneider, C Minder. BMJ 1997
26

Measuring inconsistency in meta-analyses.
Julian P T Higgins, Simon G Thompson, Jonathan J Deeks, Douglas G Altman. BMJ 2003
24

Quantifying heterogeneity in a meta-analysis.
Julian P T Higgins, Simon G Thompson. Stat Med 2002
21

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman. PLoS Med 2009
20

The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.
Matthew J Page, Joanne E McKenzie, Patrick M Bossuyt, Isabelle Boutron, Tammy C Hoffmann, Cynthia D Mulrow, Larissa Shamseer, Jennifer M Tetzlaff, Elie A Akl, Sue E Brennan,[...]. BMJ 2021
14

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials.
Julian P T Higgins, Douglas G Altman, Peter C Gøtzsche, Peter Jüni, David Moher, Andrew D Oxman, Jelena Savovic, Kenneth F Schulz, Laura Weeks, Jonathan A C Sterne. BMJ 2011
13

Meta-analysis in clinical trials.
R DerSimonian, N Laird. Control Clin Trials 1986
12

RoB 2: a revised tool for assessing risk of bias in randomised trials.
Jonathan A C Sterne, Jelena Savović, Matthew J Page, Roy G Elbers, Natalie S Blencowe, Isabelle Boutron, Christopher J Cates, Hung-Yuan Cheng, Mark S Corbett, Sandra M Eldridge,[...]. BMJ 2019
12

Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group.
D F Stroup, J A Berlin, S C Morton, I Olkin, G D Williamson, D Rennie, D Moher, B J Becker, T A Sipe, S B Thacker. JAMA 2000
10

Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement.
David Moher, Larissa Shamseer, Mike Clarke, Davina Ghersi, Alessandro Liberati, Mark Petticrew, Paul Shekelle, Lesley A Stewart. Syst Rev 2015
9

A basic introduction to fixed-effect and random-effects models for meta-analysis.
Michael Borenstein, Larry V Hedges, Julian P T Higgins, Hannah R Rothstein. Res Synth Methods 2010
8

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman. BMJ 2009
8

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations.
Gordon H Guyatt, Andrew D Oxman, Gunn E Vist, Regina Kunz, Yngve Falck-Ytter, Pablo Alonso-Coello, Holger J Schünemann. BMJ 2008
8


Meta-analysis in clinical trials revisited.
Rebecca DerSimonian, Nan Laird. Contemp Clin Trials 2015
7

GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables.
Gordon Guyatt, Andrew D Oxman, Elie A Akl, Regina Kunz, Gunn Vist, Jan Brozek, Susan Norris, Yngve Falck-Ytter, Paul Glasziou, Hans DeBeer,[...]. J Clin Epidemiol 2011
7


Interpretation of random effects meta-analyses.
Richard D Riley, Julian P T Higgins, Jonathan J Deeks. BMJ 2011
6

ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions.
Jonathan Ac Sterne, Miguel A Hernán, Barnaby C Reeves, Jelena Savović, Nancy D Berkman, Meera Viswanathan, David Henry, Douglas G Altman, Mohammed T Ansari, Isabelle Boutron,[...]. BMJ 2016
6

Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation.
Larissa Shamseer, David Moher, Mike Clarke, Davina Ghersi, Alessandro Liberati, Mark Petticrew, Paul Shekelle, Lesley A Stewart. BMJ 2015
6

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman. Ann Intern Med 2009
5

How to perform a meta-analysis with R: a practical tutorial.
Sara Balduzzi, Gerta Rücker, Guido Schwarzer. Evid Based Ment Health 2019
811
5

AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both.
Beverley J Shea, Barnaby C Reeves, George Wells, Micere Thuku, Candyce Hamel, Julian Moran, David Moher, Peter Tugwell, Vivian Welch, Elizabeth Kristjansson,[...]. BMJ 2017
5

GRADE guidelines: 3. Rating the quality of evidence.
Howard Balshem, Mark Helfand, Holger J Schünemann, Andrew D Oxman, Regina Kunz, Jan Brozek, Gunn E Vist, Yngve Falck-Ytter, Joerg Meerpohl, Susan Norris,[...]. J Clin Epidemiol 2011
5

Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions.
Miranda Cumpston, Tianjing Li, Matthew J Page, Jacqueline Chandler, Vivian A Welch, Julian Pt Higgins, James Thomas. Cochrane Database Syst Rev 2019
4

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.
Alessandro Liberati, Douglas G Altman, Jennifer Tetzlaff, Cynthia Mulrow, Peter C Gøtzsche, John P A Ioannidis, Mike Clarke, P J Devereaux, Jos Kleijnen, David Moher. J Clin Epidemiol 2009
4

Methodological quality (risk of bias) assessment tools for primary and secondary medical studies: what are they and which is better?
Lin-Lu Ma, Yun-Yun Wang, Zhi-Hua Yang, Di Huang, Hong Weng, Xian-Tao Zeng. Mil Med Res 2020
233
4

Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range.
Dehui Luo, Xiang Wan, Jiming Liu, Tiejun Tong. Stat Methods Med Res 2018
679
3

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman. J Clin Epidemiol 2009
3


Outlier and influence diagnostics for meta-analysis.
Wolfgang Viechtbauer, Mike W-L Cheung. Res Synth Methods 2010
592
3


Rayyan-a web and mobile app for systematic reviews.
Mourad Ouzzani, Hossam Hammady, Zbys Fedorowicz, Ahmed Elmagarmid. Syst Rev 2016
3

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.
Alessandro Liberati, Douglas G Altman, Jennifer Tetzlaff, Cynthia Mulrow, Peter C Gøtzsche, John P A Ioannidis, Mike Clarke, P J Devereaux, Jos Kleijnen, David Moher. PLoS Med 2009
3

Estimating the mean and variance from the median, range, and the size of a sample.
Stela Pudar Hozo, Benjamin Djulbegovic, Iztok Hozo. BMC Med Res Methodol 2005
3

Grading quality of evidence and strength of recommendations.
David Atkins, Dana Best, Peter A Briss, Martin Eccles, Yngve Falck-Ytter, Signe Flottorp, Gordon H Guyatt, Robin T Harbour, Margaret C Haugh, David Henry,[...]. BMJ 2004
3

Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves.
Patricia Guyot, A E Ades, Mario J N M Ouwens, Nicky J Welton. BMC Med Res Methodol 2012
890
3

A graphical method for exploring heterogeneity in meta-analyses: application to a meta-analysis of 65 trials.
Bertrand Baujat, Cédric Mahé, Jean-Pierre Pignon, Catherine Hill. Stat Med 2002
206
3

PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews.
Matthew J Page, David Moher, Patrick M Bossuyt, Isabelle Boutron, Tammy C Hoffmann, Cynthia D Mulrow, Larissa Shamseer, Jennifer M Tetzlaff, Elie A Akl, Sue E Brennan,[...]. BMJ 2021
573
3

Contour-enhanced meta-analysis funnel plots help distinguish publication bias from other causes of asymmetry.
Jaime L Peters, Alex J Sutton, David R Jones, Keith R Abrams, Lesley Rushton. J Clin Epidemiol 2008
770
3

Comparison of two methods to detect publication bias in meta-analysis.
Jaime L Peters, Alex J Sutton, David R Jones, Keith R Abrams, Lesley Rushton. JAMA 2006
2



The case of the misleading funnel plot.
Joseph Lau, John P A Ioannidis, Norma Terrin, Christopher H Schmid, Ingram Olkin. BMJ 2006
923
2



Assessing heterogeneity in meta-analysis: Q statistic or I2 index?
Tania B Huedo-Medina, Julio Sánchez-Meca, Fulgencio Marín-Martínez, Juan Botella. Psychol Methods 2006
2

Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide.
Tammy C Hoffmann, Paul P Glasziou, Isabelle Boutron, Ruairidh Milne, Rafael Perera, David Moher, Douglas G Altman, Virginia Barbour, Helen Macdonald, Marie Johnston,[...]. BMJ 2014
2

Pooling health-related quality of life outcomes in meta-analysis-a tutorial and review of methods for enhancing interpretability.
Kristian Thorlund, Stephen D Walter, Bradley C Johnston, Toshi A Furukawa, Gordon H Guyatt. Res Synth Methods 2011
134
2

How to do a meta-analysis.
Andy P Field, Raphael Gillett. Br J Math Stat Psychol 2010
313
2


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.